Difficult-to-treat Beh?et syndrome: A therapeutic approach
CLINICAL IMMUNOLOGY, vol.249, 2023 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 249
- Publication Date: 2023
- Doi Number: 10.1016/j.clim.2023.109272
- Journal Name: CLINICAL IMMUNOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Keywords: Behcet syndrome, Outcomes, Disease activity, Azathioprine, Personalized medicine, BEHCETS-DISEASE, DOUBLE-BLIND, FOLLOW-UP, TRIAL, APREMILAST, DIAGNOSIS, EFFICACY, PHASE-2
- Istanbul University-Cerrahpasa Affiliated: No
Abstract
Behcet syndrome is a systemic vasculitis which can involve many different organ systems. As such, treatment decisions need to be based on organ system involved. In addition, specific patient characteristics potentially predict milder or more severe course, and all these factors need to be taken into consideration when making treatment decisions. In this paper, we review the current approaches to treating Behcet syndrome patients.